163
Views
36
CrossRef citations to date
0
Altmetric
Review

Monitoring human papillomavirus prevalence in urine samples: a review

, &
Pages 67-79 | Published online: 12 Mar 2013

References

  • WalboomersJMJacobsMVHuman papillomavirus is a necessary cause of invasive cervical cancer worldwideJ Pathol19991891121910451482
  • zur HausenHPapillomavirus infections — a major cause of human cancersBiochim Biophys Acta199612882F55F788876633
  • MunozNBoschFXde SanjoseSEpidemiologic classification of human papillomavirus types associated with cervical cancerN Engl J Med2003348651852712571259
  • BoschFXde SanjoseSChapter 1: Human papillomavirus and cervical cancer — burden and assessment of causalityJ Natl Cancer Inst Monogr20033131312807939
  • AultKAEffect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trialsLancet200736995761861186817544766
  • PaavonenJJenkinsDBoschFXEfficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trialLancet200736995802161217017602732
  • Food and Drug AdministrationCenter for Biologics and Evaluation and Research, Office of Vaccines and Related Product Applications Available from: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094042.htmAccessed September 17, 2012
  • VillaLLHPV prophylactic vaccination: The first years and what to expect from nowCancer Lett2011305210611221190794
  • PaavonenJNaudPSalmeronJEfficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenLancet2009374968630131419586656
  • BlockSLBrownDRChatterjeeAClinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccinePediatr Infect Dis J20102929510119952863
  • DescampsDHardtKSpiessensBSafety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trialsHum Vaccin20095533234019221517
  • GiulianoARLazcano-PonceEVillaLImpact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccineJ Infect Dis200719681153116217955433
  • MunozNManalastasRJrPitisuttithumPSafety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trialLancet200937396791949195719493565
  • RomanowskiBde BorbaPCNaudPSSustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 yearsLancet200937497061975198519962185
  • FergusonMWilkinsonDEZhouTWHO meeting on the standardization of HPV assays and the role of the WHO HPV Laboratory Network in supporting vaccine introduction held on January 24–25, 2008, Geneva, SwitzerlandVaccine200927333734719007840
  • Monitoring the coverage and impact of human papillomavirus vaccine — report of WHO meeting, Nov 2009Wkly Epidemiol Rec2010852523724320583384
  • VorstersAMicalessiIBilckeJIevenMBogersJVan DammePDetection of human papillomavirus DNA in urine. A review of the literatureEur J Clin Microbiol Infect Dis201231562764021818524
  • CuschieriKNandwaniRMcGoughPUrine testing as a surveillance tool to monitor the impact of HPV immunization programsJ Med Virol201183111983198721915874
  • DunneEFNielsonCMStoneKMMarkowitzLEGiulianoARPrevalence of HPV infection among men: A systematic review of the literatureJ Infect Dis200619481044105716991079
  • GiulianoARNielsonCMFloresRThe optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men studyJ Infect Dis200719681146115217955432
  • SehgalAGuptaSParashariASodhaniPSinghVUrine HPV-DNA detection for cervical cancer screening: prospects and prejudicesJ Obstet Gynaecol200929758358919757259
  • PrustyBKKumarAAroraRBatraSDasBCHuman papillomavirus (HPV) DNA detection in self-collected urineInt J Gynaecol Obstet200590322322716043176
  • ManhartLEHolmesKKKoutskyLAHuman papillomavirus infection among sexually active young women in the United States: Implications for developing a vaccination strategySex Transm Dis200633850250816572039
  • O’LearyMCSinkaKRobertsonCHPV type-specific prevalence using a urine assay in unvaccinated male and female 11- to 18-year olds in ScotlandBr J Cancer201110471221122621343934
  • HussainSBharadwajMNasareVHuman papillomavirus infection among young adolescents in India: impact of vaccinationJ Med Virol201284229830522170551
  • AlamedaFBellosilloBFustePHuman papillomavirus detection in urine samples: an alternative screening methodJ Low Genit Tract Dis20071115717194943
  • BissettSLHowell-JonesRSwiftCHuman papillomavirus genotype detection and viral load in paired genital and urine samples from both females and malesJ Med Virol201183101744175121837790
  • DaponteAPournarasSMademtzisIEvaluation of high-risk human papillomavirus types PCR detection in paired urine and cervical samples of women with abnormal cytologyJ Clin Virol200636318919316690350
  • ForslundOHanssonBGRymarkPBjerreBHuman papillomavirus DNA in urine samples compared with that in simultaneously collected urethra and cervix samplesJ Clin Microbiol1993318197519798396581
  • GuptaAAroraRGuptaSHuman papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimensJ Clin Virol200637319019416931139
  • JacobsonDLWomackSDPeraltaLConcordance of human papillomavirus in the cervix and urine among inner city adolescentsPediatr Infect Dis J200019872272810959740
  • PayanCDucancelleAAboubakerMHHuman papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systemsJ Clin Microbiol200745389790117229868
  • RymarkPForslundOHanssonBGLindholmKGenital HPV infection not a local but a regional infection: experience from a female teenage groupGenitourin Med199369118228383095
  • SellorsJWLorinczATMahonyJBComparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesionsCMAJ2000163551351811006761
  • SongESLeeHJHwangTSClinical efficacy of human papillomavirus DNA detection in urine from patients with various cervical lesionsJ Korean Med Sci20072219910417297259
  • StanczukGAKayPAllanBDetection of human papillomavirus in urine and cervical swabs from patients with invasive cervical cancerJ Med Virol200371111011412858416
  • StraussSJordensJZMcBrideDDetection and typing of human papillomavirus DNA in paired urine and cervical scrapesEur J Epidemiol199915653754310485346
  • Lazcano-PonceEHerreroRMunozNHigh prevalence of human papillomavirus infection in Mexican males: comparative study of penile-urethral swabs and urine samplesSex Transm Dis200128527728011354266
  • WeaverBAFengQHolmesKKEvaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in menJ Infect Dis2004189467768514767822
  • HernandezBYWilkensLRZhuXCircumcision and human papillomavirus infection in men: a site-specific comparisonJ Infect Dis2008197678779418284369
  • ArbynMSanjoseSDSaraiyaMEUROGIN 2011 roadmap on prevention and treatment of HPV-related diseaseInt J Cancer201213191969198222623137
  • BruniLDiazMCastellsagueXFerrerEBoschFXde SanjoseSCervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findingsJ Infect Dis2010202121789179921067372
  • de SanjoseSDiazMCastellsagueXWorldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysisLancet Infect Dis20077745345917597569
  • ChessonHWEkwuemeDUSaraiyaMDunneEFMarkowitzLEThe cost-effectiveness of male HPV vaccination in the United StatesVaccine201129468443845021816193
  • Organization WHWHO HPV Laboratory Network Available from: http://www.who.int/biologicals/vaccines/hpv/en/index.htmlAccessed November 23, 2012
  • JohnsonAMMercerCHBeddowsSEpidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in men and women in BritainSex Transm Infect201288321221722261135
  • WongCASaraiyaMHaririSApproaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countriesVaccine201129587888520971113
  • AstoriGPipanCMuffatoGBottaGADetection of HPV-DNA in semen, urine and urethral samples by dot blot and PCRNew Microbiol19951821431497603341
  • RintalaMAPollanenPPNikkanenVPGrenmanSESyrjanenSMHuman papillomavirus DNA is found in the vas deferensJ Infect Dis2002185111664166712023775
  • FifeKHCoplanPMJansenKUPoor sensitivity of polymerase chain reaction assays of genital skin swabs and urine to detect HPV 6 and 11 DNA in menSex Transm Dis200330324624812616145
  • D’HauwersKDepuydtCBogersJPUrine versus brushed samples in human papillomavirus screening: study in both gendersAsian J Androl20079570571017712490
  • ShigeharaKSasagawaTKawaguchiSPrevalence of human papillomavirus infection in the urinary tract of men with urethritisInt J Urol201017656356820345431